Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Molecular basis of differentiation therapy for soft tissue sarcomas.

Luther G, Rames R, Wagner ER, Zhu G, Luo Q, Bi Y, Kim SH, Gao JL, Huang E, Yang K, Wang L, Liu X, Li M, Hu N, Su Y, Luo X, Chen L, Luo J, Haydon RC, Luu HH, Zhou L, He TC.

Trends Cancer Res. 2010;6:69-90.

2.
3.

Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.

Nishio J, Iwasaki H, Nabeshima K, Naito M.

Genet Res Int. 2011;2011:497148. doi: 10.4061/2011/497148. Epub 2011 Jul 28.

4.

Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.

Antonescu CR, Zhang L, Nielsen GP, Rosenberg AE, Dal Cin P, Fletcher CD.

Genes Chromosomes Cancer. 2011 Oct;50(10):757-64. doi: 10.1002/gcc.20897. Epub 2011 Jun 29.

5.

Case report: hemosiderotic fibrohistiocytic lipomatous lesion: a clinicopathologic characterization.

Moretti VM, Brooks JS, Ogilvie CM.

Clin Orthop Relat Res. 2010 Oct;468(10):2808-13. doi: 10.1007/s11999-010-1242-7. Epub 2010 Feb 2. Review.

Supplemental Content

Write to the Help Desk